Canton Strategic Holdings (CNTN) Retained Earnings (2020 - 2026)
Canton Strategic Holdings (CNTN) reported Retained Earnings of -$120.2 million for Q1 2026, down 204.65% on a YoY basis from $114.8 million in Q1 2025, and down 65.02% quarter-over-quarter from -$72.8 million in Q4 2025.
Canton Strategic Holdings (CNTN) Retained Earnings (2020 - 2026) Analysis & Trends
Canton Strategic Holdings has reported Retained Earnings for 7 years, with the latest figure at -$120.2 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 204.65% year-over-year to -$120.2 million; the trailing twelve-month figure through Mar 2026 stood at -$120.2 million (down 204.65% YoY), and the FY2025 full-year result was -$72.8 million, down 97.33% from the prior year.
- Retained Earnings for Q1 2026 stood at -$120.2 million, down from -$72.8 million in the prior quarter.
- The five-year high for Retained Earnings was -$9.9 million in Q1 2022, with the low at -$120.2 million in Q1 2026.
- Historically, Retained Earnings has averaged -$34.1 million across 5 years, with a median of -$27.0 million in 2024.
- Annual changes were most pronounced in 2025 — Retained Earnings sank 31.12% — and 2026, when it sank 204.65%.
- Canton Strategic Holdings' Retained Earnings stood at -$15.4 million in 2022, then slumped by 60.57% to -$24.7 million in 2023, then slumped by 49.38% to -$36.9 million in 2024, then plunged by 97.33% to -$72.8 million in 2025, then sank by 65.02% to -$120.2 million in 2026.
- The last three Retained Earnings figures came in at -$120.2 million (Q1 2026), -$72.8 million (Q4 2025), and -$43.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | -120.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120.16 Mn |
| Dec 31, 2025 | -72.82 Mn |
| Sep 30, 2025 | -43.40 Mn |
| Jun 30, 2025 | -41.30 Mn |
| Mar 31, 2025 | -39.44 Mn |
| Dec 31, 2024 | -36.90 Mn |
| Sep 30, 2024 | -33.10 Mn |
| Jun 30, 2024 | -29.28 Mn |
| Mar 31, 2024 | -27.00 Mn |
| Dec 31, 2023 | -24.70 Mn |
| Sep 30, 2023 | -22.20 Mn |
| Jun 30, 2023 | -20.41 Mn |
| Mar 31, 2023 | -18.07 Mn |
| Dec 31, 2022 | -15.38 Mn |
| Sep 30, 2022 | -13.62 Mn |
| Jun 30, 2022 | -11.49 Mn |
| Mar 31, 2022 | -9.85 Mn |
| Dec 31, 2021 | -6.91 Mn |
| Dec 31, 2020 | -4.70 Mn |